Search

everythinglearnresearchcommunity

for

Search:↓

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

SDG helps reduce BPH effects in rats.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

The treatment combination is effective and generally safe for lung cancer.

The hydrogel effectively stops bleeding and heals diabetic wounds quickly.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

The formulation significantly increased hair density and thickness safely in people with androgenetic alopecia.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

The new fluoroquinolone effectively fights certain bacteria.

Minoxidil treatment improves heart defects in a DiGeorge syndrome model.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.